BKV Corp. IPO’d on Sept. 26, nearly two years after the Barnett Shale’s top gas producer first filed to go public.

Shares of BKV Corp—a unit of Thailand’s billionaire Vongkusolkit family's Banpu—closed flat in its trading debut on Thursday ...

The U.S. IPO market has bounced back strongly in 2024 after a nearly two-year dry spell, driven by receding recession fears ...

Obesity-drug developer BioAge Labs Inc. gained nearly 30% after its initial public offering on Thursday, while natural-gas producer BKV Inc.'s rose about 3% over its $18 IPO price. BioAge (BIOA) stock ...

BKV shares rose by 3.1% on their New York Stock Exchange debut on Thursday. This gives the U.S. Natural Gas Producer a market cap of $1.56 Billion.

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

Chris Kalnin, BKV CEO, joins 'Money Movers' to discuss the company's IPO today, what investors need to know about the state ...

Obesity-drug developer BioAge held on to a slim gain after rising more than 20%, while Texas-based Barnett Shale driller BKV ...

Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.

BioAge Labs (BIOA), which is developing a drug to augment popular weight-loss medications such as Wegovy and Zepbound, has upsized its proposed IPO. Read more here.

BKV Corp. priced its common shares at $18 each after and will begin trading on Sept. 26, about two years after the Denver ...

BKV Corporation BKV IPO will take place September, 26 on the NYSE exchange under the ticker BKV. The company is offering shares at an expected price between $19.00 and $21.00 per share with an insider ...